Wakefield, MA (PRWEB) April 24, 2014
TraceLink Inc., the leader in pharmaceutical serialization, track and trace and supply network towers for global Life Sciences, announced today that the company has reached new milestones as use of the TraceLink Life Sciences Cloud rapidly expands across the global pharmaceutical supply chain. With 17 major new customer signings to date in 2014, TraceLink is now a trusted partner by eight of the top 12 pharmaceutical companies in ensuring track and trace compliance and improving supply network performance across the globe.
TraceLink has seen rapid company growth and broad adoption of the Life Sciences Cloud platform continue in 2014 as companies prepare for US Drug Supply Chain Security Act (DSCSA) compliance, meet expanded China requirements and architect for new Brazil ANVISA regulations. In the first quarter of 2014 alone, the Life Sciences Cloud managed end-to-end China serialization and compliance reporting for over 5.5 million pharmaceutical products. New TraceLink customers now working with the TraceLink Network Management Services team will add an additional 14,000 trading partners onto the TraceLink Network during the course of 2014 in preparation for DSCSA (Drug Quality and Security Act Title II) 2015 deadlines.
“Our business grew by 400% from Q1 2013 to Q1 2014 because the market clearly recognizes the quality and completeness of our products and services,” said Shabbir Dahod, President and CEO of TraceLink. “We win the trust of our customers by being a true long-term partner that reduces the risk, cost and time to compliance while creating new business value opportunities.”
The foundation of the Life Sciences Cloud is TraceLink’s secure cloud-based network platform running in the global Amazon AWS Cloud. The Life Sciences Cloud is the only cloud solution designed from the ground up for mission-critical Life Sciences operations. TraceLink delivers full validation, encrypted data security and complete audit-trailing on top of the global availability, redundancy and cost-effective scalability provided by AWS Cloud. As a result, TraceLink meets the stringent requirements of the most sophisticated pharmaceutical companies.
The TraceLink Life Sciences Cloud provides a highly connected and agile network linking pharmaceutical companies, CMO/CPOs, 3PLs, wholesale distributors and pharmacies. Through a single link to the TraceLink Life Sciences Cloud, any company regardless of size or technical capabilities gains: (1) full global track and trace compliance, (2) complete connectivity to all supply and trading partners in their business network and (3) comprehensive outsourced network management.
Leading companies turn to TraceLink, the only company with a decade of dedication to building Life Sciences supply chain solutions, for:
Learn more about TraceLink’s pharmaceutical track and trace solutions and supply network tower applications at http://www.tracelink.com.
TraceLink protects patients, enables health, grows profits and ensures compliance for companies across the global Life Sciences network through the TraceLink Life Sciences Cloud. The TraceLink Life Sciences Cloud is an Amazon AWS-based cloud application platform which enables complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is trusted by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit http://www.tracelink.com or follow us on LinkedIn.
TraceLink is funded by FirstMark Capital. FirstMark Capital is an early stage venture capital firm based in New York City. FirstMark’s mission is to partner with exceptional entrepreneurs who are changing the world by solving meaningful problems. FirstMark has built a deeply engaged community among the extraordinary teams in the FirstMark network to spread ideas and opportunities. FirstMark is privileged to work alongside the founders of remarkable businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit FirstMark in New York City or online at firstmarkcap.com and @FirstMarkCap.